Clive S Grant

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006
    Clive S Grant
    Department of Gastrointestinal and General Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    World J Surg 34:1239-46. 2010
  2. ncbi Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience
    Clive S Grant
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Arch Surg 140:472-8; discussion 478-9. 2005
  3. ncbi Insulinoma
    Clive S Grant
    Department of Surgery, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street, SW Rochester, MN 55905, USA
    Best Pract Res Clin Gastroenterol 19:783-98. 2005
  4. ncbi The value of positron emission tomography in the surgical management of recurrent papillary thyroid carcinoma
    Clive S Grant
    Department of Surgery, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota 55905, USA
    World J Surg 32:708-15. 2008
  5. ncbi Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study
    Clive S Grant
    Division of General Surgery, Mayo Clinic, North Central Cancer Treatment Group, Dept of Surgery, 200 1st St SW, Rochester, MN 55905, USA
    J Clin Oncol 27:3620-6. 2009
  6. ncbi Setting the bar for laparoscopic resection of sporadic insulinoma
    Melanie L Richards
    Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN 55905, USA
    World J Surg 35:785-9. 2011
  7. ncbi Focused cervical exploration for primary hyperparathyroidism without intraoperative parathyroid hormone monitoring or use of the gamma probe
    Steven R Jacobson
    Division of Gastroenterologic and General Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    World J Surg 28:1127-31. 2004
  8. ncbi Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease
    Kimberly A Vanderveen
    Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA
    Surgery 148:1237-45; discussion 1245-6. 2010
  9. ncbi Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout
    Irina Bancos
    Department of Endocrinology, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    Endocr Pract 18:441-9. 2012
  10. ncbi Thyroid cancer detection with dual-isotope parathyroid scintigraphy in primary hyperparathyroidism
    Edwin O Onkendi
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 19:1446-52. 2012

Detail Information

Publications79

  1. ncbi Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006
    Clive S Grant
    Department of Gastrointestinal and General Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    World J Surg 34:1239-46. 2010
    ..We examined the safety and efficacy of an optimized surgical approach including preoperative ultrasonography (US), bilateral thyroidectomy, routine compartment VI dissection, and lateral neck dissection for LNM...
  2. ncbi Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience
    Clive S Grant
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Arch Surg 140:472-8; discussion 478-9. 2005
    ..Changes in the management of primary HPT have occurred since introducing MIP including localization, anesthesia, intraoperative parathyroid hormone monitoring, and indications for parathyroidectomy...
  3. ncbi Insulinoma
    Clive S Grant
    Department of Surgery, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street, SW Rochester, MN 55905, USA
    Best Pract Res Clin Gastroenterol 19:783-98. 2005
    ..The most recent developments in this area are the recognition of noninsulinoma pancreatogenous hypoglycemia syndrome as a cause of organic hypoglycemia, and the development of laparoscopic techniques to excise these tumours...
  4. ncbi The value of positron emission tomography in the surgical management of recurrent papillary thyroid carcinoma
    Clive S Grant
    Department of Surgery, Mayo Clinic, 200 1st Street SW, Rochester, Minnesota 55905, USA
    World J Surg 32:708-15. 2008
    ..Our aim was to determine the comparative value of F18-fluorodeoxyglucose positron emission tomography (PET) to US for localization of locoregional recurrence in patients who underwent reoperation for recurrent PTC...
  5. ncbi Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study
    Clive S Grant
    Division of General Surgery, Mayo Clinic, North Central Cancer Treatment Group, Dept of Surgery, 200 1st St SW, Rochester, MN 55905, USA
    J Clin Oncol 27:3620-6. 2009
    ....
  6. ncbi Setting the bar for laparoscopic resection of sporadic insulinoma
    Melanie L Richards
    Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN 55905, USA
    World J Surg 35:785-9. 2011
    ..The purpose of this study was to identify the skills and technology needed for LIR and establish outcome standards...
  7. ncbi Focused cervical exploration for primary hyperparathyroidism without intraoperative parathyroid hormone monitoring or use of the gamma probe
    Steven R Jacobson
    Division of Gastroenterologic and General Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    World J Surg 28:1127-31. 2004
    ..Further experience with this surgical approach seems warranted to determine the overall cure rate, operative morbidity, and the sensitivity and specificity of preoperative localization studies...
  8. ncbi Outcomes and quality of life after partial pancreatectomy for noninsulinoma pancreatogenous hypoglycemia from diffuse islet cell disease
    Kimberly A Vanderveen
    Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA
    Surgery 148:1237-45; discussion 1245-6. 2010
    ..The study goal was to assess frequency and severity of recurrent symptoms in operated patients...
  9. ncbi Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout
    Irina Bancos
    Department of Endocrinology, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    Endocr Pract 18:441-9. 2012
    ..To describe the experience with parathyroid fine-needle aspiration (FNA) and parathyroid hormone (PTH) washout at Mayo Clinic Rochester, Rochester, Minnesota...
  10. ncbi Thyroid cancer detection with dual-isotope parathyroid scintigraphy in primary hyperparathyroidism
    Edwin O Onkendi
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 19:1446-52. 2012
    ..Our aim was to determine whether dual-isotope parathyroid scintigraphy is useful in identifying thyroid cancer...
  11. ncbi Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)]
    Amy C Degnim
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 17:2685-9. 2010
    ..2 mm [N0(i+)]. Our goal was to characterize patients with SLN isolated tumor cells regarding surgical management and axillary recurrence...
  12. ncbi Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not?
    Benzon M Dy
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 19:2272-8. 2012
    ..However, patients with negative imaging may not be referred for surgery or the surgeon may be reluctant to operate. We compare outcomes in patients with negative imaging to those with localization...
  13. ncbi Primary aldosteronism: results of adrenalectomy for nonsingle adenoma
    Amy R Quillo
    Department of Surgery, University of Louisville, Louisville, KY, USA
    J Am Coll Surg 213:106-12; discussion 112-3. 2011
    ....
  14. ncbi Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer
    John M Stulak
    Department of Gastrointestinal and General Surgery, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Arch Surg 141:489-94; discussion 494-6. 2006
    ..9%) of the 702 patients with PTC who underwent US, thereby altering the operative procedure performed. In addition, even in patients with palpable LNs, US helped to guide the extent of lymphadenectomy...
  15. ncbi Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy
    Robert L Foote
    Endocrine Malignancies Disease Oriented Group, Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, USA
    Thyroid 21:25-30. 2011
    ....
  16. ncbi Biopsy of pheochromocytomas and paragangliomas: potential for disaster
    Kimberly A Vanderveen
    Department of Surgery, Mayo Medical School, Rochester, MN, USA
    Surgery 146:1158-66. 2009
    ..Percutaneous biopsy has been associated with life-threatening hemorrhage, hypertensive crisis, capsular disruption with tumor implantation, and death. We sought to determine the outcomes of biopsy in 20 consecutive patients...
  17. ncbi Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?
    Shaheen Zakaria
    Department of Surgery, Mayo Clinic, Rochester, Minn 55905, USA
    Surgery 143:641-7. 2008
    ..This study was designed to assess locoregional recurrence in patients with positive SNs who did not undergo CALND...
  18. ncbi Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring
    Melanie L Richards
    Mayo Clinic, Department of Surgery, Rochester, MN, USA
    Am J Surg 196:937-42; discussion 942-3. 2008
    ..This study evaluated R-PTX during the era of minimal-access PTX with intraoperative parathyroid hormone (IOPTH) monitoring...
  19. ncbi A single-center experience with inflammatory breast cancer, 1985-2003
    Rory L Smoot
    Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Arch Surg 141:567-72; discussion 572-3. 2006
    ..CONCLUSIONS: Survival from IBC remains poor. Although adenopathy and radiotherapy affected survival by multivariate analysis, the sequence of therapy was not associated with improved outcome...
  20. ncbi Adrenalectomy improves outcomes of selected patients with metastatic carcinoma
    Bianca J Vazquez
    Division of Gastroenterologic and General Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    World J Surg 36:1400-5. 2012
    ..Mayo Clinic institutional outcomes in patients with metastatic disease to the adrenal(s) treated by adrenalectomy were compared to stage-matched historical controls from the Surveillance Epidemiology and End Results (SEER) database...
  21. ncbi Need for a revised staging consensus in medullary thyroid carcinoma
    Sarah Y Boostrom
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Arch Surg 144:663-9. 2009
    ..Assessing prognosis for medullary thyroid cancer remains challenging and inexact. We hypothesize that the 1997 TNM staging criteria, especially for stage IV, are more accurate than the current 2002 staging system...
  22. ncbi Reliability of benign fine needle aspiration cytology of large thyroid nodules
    John R Porterfield
    Division of Gastroenterologic and General Surgery, Mayo Clinic, Mayo Graduate School of Medicine, Rochester, Minn, USA
    Surgery 144:963-8; discussion 968-9. 2008
    ..Our aim was to determine the false negative rate of FNA cytology on thyroid nodules >/=3 cm interpreted as benign at our institution...
  23. ncbi Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period
    Ian D Hay
    Division of Endocrinology and Internal Medicine, Mayo Clinic and College of Medicine, Rochester, Minn, USA
    Surgery 144:980-7; discussion 987-8. 2008
    ..The study aims were to characterize patients with papillary thyroid microcarcinoma (PTM) and to describe post-surgical outcome...
  24. ncbi Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyroidism?
    Shelby H Burkey
    Department of Surgery, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, Minnesota 55905, USA
    World J Surg 26:914-20. 2002
    ..The probe is more expensive and was not a consistently reliable tool for localizing parathyroid pathology. PTH monitoring reliably predicts cure intraoperatively...
  25. ncbi Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients
    Ian D Hay
    Department of Internal Medicine, Division of Endocrinology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    World J Surg 26:879-85. 2002
    ..Increasing use of RRA has not apparently improved the already excellent outcome, achieved before 1970, in low risk (MACIS <6) PTC patients managed by near-total thyroidectomy and conservative nodal excision...
  26. ncbi The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses
    William F Young
    Division of Endocrinology, Department of Radiology, Mayo Clinic Rochester, 200 First Street SW, Rochester, Minnesota 55905, USA
    World J Surg 32:856-62. 2008
    ..We report our experience with adrenal venous sampling (AVS) in the evaluation of 10 patients with bilateral masses who had ACTH-independent CS or subclinical CS...
  27. ncbi Current applications of the intraoperative parathyroid hormone assay in parathyroid surgery
    Melanie L Richards
    Mayo Clinic, Department of Surgery, 200 First Street SW, Rochester, MN 55905, USA
    Am Surg 73:311-7. 2007
    ..The purpose of this review is to provide the surgeon with the practical points and pitfalls of the use of intraoperative parathyroid hormone in the treatment of parathyroid disease...
  28. ncbi The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma
    Rasa Zarnegar
    Department of Surgery, Weill Cornell Medical College, New York, NY 10021, USA
    Ann Surg 247:511-8. 2008
    ..To develop a prediction model using information readily available, at clinical presentation, which could determine whether patients with aldosterone-producing adenomas would have complete resolution of hypertension after adrenalectomy...
  29. ncbi Comparison of ultrasound-guided fine-needle aspiration biopsy with core-needle biopsy in the evaluation of thyroid nodules
    Teck Kim Khoo
    Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota, USA
    Endocr Pract 14:426-31. 2008
    ..To compare the diagnostic rate of ultra-sound-guided fine-needle aspiration biopsy (FNAB) with the diagnostic rate of combined FNAB and core-needle biopsy in the evaluation of nodular thyroid disease...
  30. ncbi Sensitivity and utility of parathyroid scintigraphy in patients with primary versus secondary and tertiary hyperparathyroidism
    Tuan H Pham
    Department of Surgery, Mayo Clinic, 200 Second Street SW, Rochester, Minnesota 55901, USA
    World J Surg 30:327-32. 2006
    ..Its sensitivity is low in secondary and tertiary HPT patients. Thus PS has limited value as a preoperative localization study in secondary/tertiary HPT patients...
  31. ncbi Percutaneous parathyroid ethanol ablation in patients with multiple endocrine neoplasia type 1
    Mark W Veldman
    Department of Radiology, Mayo Clinic, 200 1st St, SW, Rochester, MN 55902, USA
    AJR Am J Roentgenol 191:1740-4. 2008
    ..CONCLUSION: Ethanol ablation is a viable alternative to reoperation for the management of recurrent primary hyperparathyroidism in patients with MEN1...
  32. ncbi Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience
    John T Chow
    Division of Endocrinology, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Clin Endocrinol (Oxf) 68:513-9. 2008
    ....
  33. ncbi Changes in bone mineral density after surgical intervention for primary hyperparathyroidism
    Benzon M Dy
    Department of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN
    Surgery 152:1051-8. 2012
    ..We sought to determine bone mineral density improvement after successful surgery and associated factors...
  34. ncbi Surgery for Cushing's syndrome: an historical review and recent ten-year experience
    John R Porterfield
    Department of Surgery, Mayo Clinic and Mayo Foundation, 200 First Street, S W, Rochester, MN 55905, USA
    World J Surg 32:659-77. 2008
    ....
  35. ncbi Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987-2007
    Kimberly A Placzkowski
    Department of Medicine, Division of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 94:1069-73. 2009
    ..The objective of the study was to assess changes in the presentation and diagnostic and radiological evaluation of patients with surgically confirmed insulinoma at the Mayo Clinic 1987-2007...
  36. ncbi Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging
    Rajini Katipamula
    Department of Oncology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    J Clin Oncol 27:4082-8. 2009
    ..We sought to analyze the trends in mastectomy rates and the relationship to preoperative MRI and surgical year at Mayo Clinic, Rochester, MN...
  37. ncbi de Quervain's thyroiditis: surgical experience
    Troy M Duininck
    Division of Gastroenterologic and General Surgery, Mayo Clinic Rochester, Rochester, Minnesota 55905, USA
    Endocr Pract 8:255-8. 2002
    ..Patients with atypical features and ones with euthyroidism are more likely candidates than others for surgical intervention...
  38. ncbi Laparoscopic adrenalectomy for pheochromocytoma
    Dawn E Jaroszewski
    Department of Surgery, Mayo Clinic, Scottsdale, AZ 85259, USA
    Mayo Clin Proc 78:1501-4. 2003
    ..Although there have been no recurrences to date, long-term follow-up is required for all patients, especially those with hereditary forms of pheochromocytomas...
  39. ncbi Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life
    Y Nancy You
    Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Surgery 142:829-36; discussion 836.e1. 2007
    ..Potential oncologic benefits of PD resection must be weighed against operative morbidities, compromised pancreatic function, and quality of life (QOL)...
  40. ncbi Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer
    D Kay Blanchard
    Department of Surgery, Mayo Clinic, Rochester, Minn 55905, USA
    Arch Surg 138:482-7; discussion 487-8. 2003
    ..Biopsy of the SLN was associated with significantly less morbidity than completion axillary dissection...
  41. ncbi Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression
    Kandelaria M Rumilla
    Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55901, USA
    Mod Pathol 22:239-45. 2009
    ..These findings suggest that increased production of growth factors and growth factor receptors may contribute to the development of nesidioblastosis in adults...
  42. ncbi Concurrent resections of pancreatic islet cell cancers with synchronous hepatic metastases: outcomes of an aggressive approach
    Juan M Sarmiento
    Division of Gastroenterologic and General Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Surgery 132:976-82; discussion 982-3. 2002
    ..Because disease progression is frequent and the major cause of death, investigations of adjuvant and adjunctive therapies are warranted...
  43. ncbi Adrenal venous sampling for catecholamines: a normal value study
    E Marie Freel
    Division of Endocrinology, Diabetes, Metabolism, Nutrition, and Internal Medicine, Mayo Clinic Rochester, 200 First Street SW, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 95:1328-32. 2010
    ..the left adrenal vein; in the case of epinephrine, up to an 83-fold difference was found between the right and left adrenal veins. These data highlight why AVS should not be used in the investigation of adrenal pheochromocytoma...
  44. ncbi Palpable presentation of breast cancer persists in the era of screening mammography
    Kellie L Mathis
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN, USA
    J Am Coll Surg 210:314-8. 2010
    ..The aim was to describe cancer detection method and frequency of screening mammography in women undergoing breast cancer surgery in 2000...
  45. ncbi Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma
    Toby N Weingarten
    Department of Anesthesiology and Anesthesia Clinical Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Urology 76:508.e6-11. 2010
    ..However, no consensus has been reached regarding the best preoperative preparation regimen...
  46. ncbi Evidence-based management of toxic multinodular goiter (Plummer's Disease)
    John R Porterfield
    Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    World J Surg 32:1278-84. 2008
    ..Toxic multinodular goiter (Plummer's disease) has posed challenges to surgeons, endocrinologists, and radiation oncologists since its description in 1913. A literature review with evidenced-based methodology has not yet been reported...
  47. ncbi Parathyroid carcinoma: is there a role for adjuvant radiation therapy?
    Nathan D Munson
    Division of Radiation Oncology, Mayo Clinic, Mayo Medical School, and Mayo Foundation, Rochester, Minnesota 55905, USA
    Cancer 98:2378-84. 2003
    ....
  48. ncbi Aldosterone-secreting adrenocortical carcinomas are associated with unique operative risks and outcomes
    Michael L Kendrick
    Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Surgery 132:1008-11; discussion 1012. 2002
    ..Although patients harboring aldosterone-secreting ACC appear to have an increased risk of perioperative death, survivors may have an improved overall survival rate compared with patients with non-aldosterone-secreting ACC...
  49. ncbi Role for adrenal venous sampling in primary aldosteronism
    William F Young
    Division of Endocrinology, Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, NY 55905, USA
    Surgery 136:1227-35. 2004
    ..7%) might have had unnecessary or inappropriate adrenalectomy. AVS is an essential diagnostic step in most patients to distinguish between unilateral and bilateral adrenal aldosterone hypersecretion...
  50. ncbi Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma
    Travis E Grotz
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Mayo Clin Proc 86:522-8. 2011
    ....
  51. ncbi Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease
    Robert A Wermers
    Division of Endocrinology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    J Bone Miner Res 21:171-7. 2006
    ..The lower rates previously noted persisted, whereas parathyroidectomies at our institution remained high. These data suggest an etiologic factor may be responsible for the peak incidence in the 1970s...
  52. ncbi Malignant adrenal neoplasm masquerading as worrisome adrenal hemorrhage
    Luis A Benavente-Chenhalls
    Division of Gastroenterologic and General Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA
    Ann Surg Oncol 17:2710-3. 2010
    ..Adrenal hemorrhage (AH) associated with adrenal neoplasm is rare. This study assesses the clinical and pathological impact of AH in the setting of malignant adrenal neoplasm to establish management strategies...
  53. ncbi Trends in surgical treatment of breast cancer at Mayo Clinic 1980-2004
    Robert L Foote
    Department of Radiation Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Breast 17:555-62. 2008
    ....
  54. ncbi Primary nonphylloides breast sarcomas
    D Kay Blanchard
    Department of Surgery, Mayo W-6, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Am J Surg 186:359-61. 2003
    ..Adjuvant chemotherapy and radiation did not improve survival in this report. Surgical extirpation remains the only effective treatment...
  55. ncbi An optimal algorithm for intraoperative parathyroid hormone monitoring
    Melanie L Richards
    Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Arch Surg 146:280-5. 2011
    ..A minimally invasive approach to primary hyperparathyroidism is equivalent to bilateral exploration when intraoperative parathyroid hormone (IOPTH) monitoring is used. The optimal strategy for the monitoring has been debated...
  56. ncbi The predictive value of laboratory findings in patients with primary hyperparathyroidism
    Geza Mozes
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
    J Am Coll Surg 194:126-30. 2002
    ..We pondered the relative usefulness of routine laboratory studies to the surgeon as predictive guides to the intraoperative findings in patients with primary hyperparathyroidism (HPT)...
  57. ncbi Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers
    Keith C Bible
    Mayo Clinic, Rochester, MN 55905, USA
    Am J Manag Care 18:e162-7. 2012
    ..We therefore sought to build interest in endocrine cancers, improve physician experience, and develop innovative approaches to treating patients with these neoplasms...
  58. ncbi Thoracic metastasectomy for thyroid malignancies
    John Roland Porterfield
    Division of General Thoracic Surgery, Mayo Clinic, Rochester, Minnesota, USA
    Eur J Cardiothorac Surg 36:155-8. 2009
    ..To better define early and long-term outcomes of patients undergoing thoracic metastasectomy for thyroid cancer...
  59. ncbi Operative technique for modified radical neck dissection in papillary thyroid carcinoma
    John R Porterfield
    Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Arch Surg 144:567-74; discussion 574. 2009
    ..Current intense postoperative surveillance by endocrinologists nationwide has the sensitivity to detect even minute lymph node metastases using ultrasonography, radioactive iodine scan, and thyroglobulin monitoring...
  60. ncbi Intraoperative electromyographic monitoring of the recurrent laryngeal nerve in reoperative thyroid and parathyroid surgery
    Donald E Yarbrough
    Department of Surgery, College of Medicine, Mayo Clinic, Mayo Building W6, 200 First Street SW, Rochester, MN 55905, USA
    Surgery 136:1107-15. 2004
    ..Experience and routine nerve exposure remain crucial to the minimization of RLN complications...
  61. ncbi Risk factors for recurrence and death after primary surgical treatment of malignant phyllodes tumors
    Oktar Asoglu
    Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Ann Surg Oncol 11:1011-7. 2004
    ..Malignant phyllodes tumor (MPT) is a rare but aggressive breast malignancy. The aim of this study was to evaluate parameters that influence outcome in patients with MPT...
  62. ncbi Image of the month. A second insulinoma
    D Dean Potter
    Department of Surgery, Mayo Clinic and Mayo College of Medicine, Rochester, Minn, USA
    Arch Surg 140:611-2. 2005
  63. ncbi Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance
    Marlene H Frost
    Division of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Oncol 23:7849-56. 2005
    ..The purpose of this research is to evaluate women's long-term satisfaction with CPM, factors influencing satisfaction, and psychological and social function after CPM...
  64. ncbi Surgical management of recurrent subareolar breast abscesses: Mayo Clinic experience
    Sean Li
    Department of Surgery, Mayo Clinic, 200 First St. SW, E12 Mayo Bldg, Rochester, MN 55905, USA
    Am J Surg 192:528-9. 2006
    ..CONCLUSIONS: This technique achieves a cure rate of 91% and an overall 95% satisfaction rate in the cosmetic outcome of the nipple...
  65. ncbi Surgical management of Graves disease in childhood and adolescence: an institutional experience
    Jonathan Sherman
    Division of Gastroenterologic and General Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Surgery 140:1056-61; discussion 1061-2. 2006
    ..In 5% of patients, surgical management allowed for detection and treatment of clinically occult thyroid malignancies...
  66. ncbi Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience
    Scott G Houghton
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    World J Surg 28:1083-7. 2004
    ..The cardiovascular co-morbidities and high operative risk in this group of patients may account for the increased complication rate...
  67. ncbi Malignant melanoma in the 21st century: the emerging molecular landscape
    Aleksandar Sekulic
    Department of Dermatology, Mayo Clinic, Scottsdale, AZ 85259, USA
    Mayo Clin Proc 83:825-46. 2008
    ..We review the emerging molecular landscape of melanoma and its implications for better management of patients with melanoma...
  68. ncbi Labile hypertension, increased metanephrines and imaging misadventures
    Vesna D Garovic
    Divisions of Hypertension and Nephrology, Mayo Clinic, Rochester, MN, USA
    Nephrol Dial Transplant 19:1004-6. 2004
  69. ncbi Sentinel lymph node biopsy for breast cancer: is two-site injection best?
    Amy C Degnim
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Surgery 139:630-2. 2006
  70. ncbi Current treatment of nodular goiter with hyperthyroidism (Plummer's disease): surgery versus radioiodine
    Ajaipal S Kang
    Division of Gastroenterologic and General Surgery, Mayo Clinic and Mayo Foundation, 200 2nd Street SW, Rochester, MN 55905, USA
    Surgery 132:916-23; discussion 923. 2002
    ..RAI is also safe and effective, usually requiring a single dose, but the results are delayed and it usually fails to resolve a goiter...
  71. ncbi Breast biopsy utilization: a population-based study
    Karthik Ghosh
    Division of General Internal Medicine, Department of Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Arch Intern Med 165:1593-8. 2005
    ..A multidisciplinary breast practice, along with established guidelines for breast biopsy, can ensure appropriate use of new technology and thereby improve patient care...
  72. ncbi Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery
    Mercedeh Baghai
    Department of Surgery, Mayo Clinic and Mayo Foundation, 200 First St SW, Rochester, MN 55905, USA
    Arch Surg 137:682-8; discussion 688-9. 2002
    ..Early intervention and advanced surgical techniques better allow for cortical-sparing and laparoscopic procedures. With low recurrence rates, corticosteroid independence can be maintained for prolonged periods...
  73. ncbi Radiation-induced breast sarcoma
    D Kay Blanchard
    Department of Surgery, Mayo W-6, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg 184:356-8. 2002
    ..The prognosis of such patients is poor, with two thirds dying of their disease. In the present series, improved survival was associated with smaller tumor size at presentation...
  74. ncbi Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
    Thorvardur R Halfdanarson
    Division of Oncology, Department of Medical Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Endocr Relat Cancer 15:409-27. 2008
    ..The epidemiology, prognosis, and established and novel prognostic markers of PETs are reviewed...
  75. ncbi Presidential address: Boiling water to iodine--a story of unparalleled collaboration
    Clive S Grant
    Department of Surgery, Mayo Medical School, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
    Surgery 132:909-15. 2002
  76. ncbi Breast cancer: presentation and intervention in women with gastrointestinal metastasis and carcinomatosis
    Elisabeth C McLemore
    Division of General Surgery, Mayo Clinic, 13400 East Shea Boulevard, Scottsdale, Arizona 85259, USA
    Ann Surg Oncol 12:886-94. 2005
    ..CONCLUSIONS: Gastrointestinal metastasis occurred more often in patients with invasive lobular carcinoma. Surgical intervention did not significantly extend overall survival but may be considered in a select group of patients...
  77. ncbi Mayo Clinic general surgery training legacy
    David R Farley
    Arch Surg 138:7-8. 2003
  78. ncbi Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung
    Anna G Taranova
    Department of Biochemistry and Molecular Biology, Divisions of Pulmonary Medicine, Mayo Clinic Arizona, Scottsdale, Arizona 85259, USA
    Cancer Res 68:8582-9. 2008
    ....
  79. ncbi Adrenocortical carcinoma survival rates correlated to genomic copy number variants
    Elizabeth A Stephan
    Genetic Basis of Human Disease Division, Translational Genomics Research Institute, 445 North 5th Street, Phoenix, AZ 85004, USA
    Mol Cancer Ther 7:425-31. 2008
    ..These regions may hold prognostic indicators and offer therapeutic targets that can be used to develop novel treatments for aggressive tumors...